Concepedia

Richard Arndt

RA

Statistics

Publications

10

Citations

495

H-Index

10

Active since

2015

Affiliations

Mayo Clinic in Florida(Current)

Mayo Clinic Health System

WinnMed

Mayo Clinic Hospital

Mayo Clinic

Richard Arndt is an author at Mayo Clinic in Florida specializing in infectious diseases, pharmacotherapy, and treatment of coronavirus infections.

ORCID

Publications per year

2015–2022

10

Publications

10

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19

Raymund R. Razonable, Colin Pawlowski, John C. O’Horo et al. · EClinicalMedicine · 2021 · 134 citations · Full text

, , +8

Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

Ravindra Ganesh, Lindsey M. Philpot, Dennis M. Bierle et al. · The Journal of Infectious Diseases · 2021 · 102 citations · Full text

, , +10

A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19

Raymund R. Razonable, Nicole C.E. Aloia, Ryan J. Anderson et al. · Mayo Clinic Proceedings · 2021 · 54 citations · Full text

, , +17

Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19

Ravindra Ganesh, Colin Pawlowski, John C. O’Horo et al. · Journal of Clinical Investigation · 2021 · 46 citations · Full text

, , +7

Pharmacist Impact on Ischemic Stroke Care in the Emergency Department

Rena Gosser, Richard Arndt, Kate Schaafsma et al. · Journal of Emergency Medicine · 2015 · 39 citations · Full text

, , +16

1–5 of 10